BioNexus Gene Lab Past Earnings Performance
Past criteria checks 0/6
BioNexus Gene Lab's earnings have been declining at an average annual rate of -64.2%, while the Trade Distributors industry saw earnings growing at 25.3% annually. Revenues have been growing at an average rate of 14.3% per year.
Key information
-64.2%
Earnings growth rate
-59.3%
EPS growth rate
| Trade Distributors Industry Growth | 23.4% |
| Revenue growth rate | 14.3% |
| Return on equity | -10.0% |
| Net Margin | -10.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How BioNexus Gene Lab makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 9 | -1 | 3 | 0 |
| 30 Jun 24 | 9 | -2 | 4 | 0 |
| 31 Mar 24 | 10 | -3 | 4 | 0 |
| 31 Dec 23 | 10 | -3 | 4 | 0 |
| 30 Sep 23 | 10 | -3 | 5 | 0 |
| 30 Jun 23 | 10 | -1 | 2 | 0 |
| 31 Mar 23 | 10 | 0 | 2 | 0 |
| 31 Dec 22 | 11 | 0 | 2 | 0 |
| 30 Sep 22 | 11 | 0 | 1 | 0 |
| 30 Jun 22 | 12 | 0 | 1 | 0 |
| 31 Mar 22 | 13 | 0 | 1 | 0 |
| 31 Dec 21 | 13 | 1 | 1 | 0 |
| 30 Sep 21 | 14 | 0 | 2 | 0 |
| 30 Jun 21 | 14 | 0 | 1 | 0 |
| 31 Mar 21 | 12 | 0 | 1 | 0 |
| 31 Dec 20 | 11 | 1 | 1 | 0 |
| 30 Sep 20 | 7 | 1 | 1 | 0 |
| 30 Jun 20 | 4 | 1 | 1 | 0 |
| 31 Mar 20 | 3 | 1 | 1 | 0 |
| 31 Dec 19 | 0 | 0 | 0 | 0 |
| 30 Sep 19 | 0 | 0 | 0 | 0 |
| 30 Jun 19 | 0 | 0 | 0 | 0 |
| 31 Mar 19 | 0 | 0 | 0 | 0 |
| 31 Dec 18 | 0 | 0 | 0 | 0 |
| 30 Sep 18 | 0 | 0 | 0 | 0 |
| 31 Dec 17 | 0 | 0 | 0 | 0 |
Quality Earnings: BGLC is currently unprofitable.
Growing Profit Margin: BGLC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BGLC is unprofitable, and losses have increased over the past 5 years at a rate of 64.2% per year.
Accelerating Growth: Unable to compare BGLC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BGLC is unprofitable, making it difficult to compare its past year earnings growth to the Trade Distributors industry (-5.4%).
Return on Equity
High ROE: BGLC has a negative Return on Equity (-10.03%), as it is currently unprofitable.